Enovis (ENOV) Free Cash Flow (2010 - 2026)
Enovis' (ENOV) quarterly Free Cash Flow came in at -$28.9 million in Q2 2026, up 35.68% year-on-year from -$21.3 million in Q2 2025, and down 189.36% on a QoQ basis from $32.3 million in Q4 2025.
Enovis (ENOV) Free Cash Flow (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Free Cash Flow data on file, last reported at -$28.9 million in Q2 2026.
- On a quarterly basis, Free Cash Flow rose 35.68% year-over-year to -$28.9 million in Q2 2026; TTM through Apr 2026 was $35.9 million, a 192.15% increase from a year earlier, with the FY2025 full-year figure at $19.9 million, up 129.63% from the prior year.
- Free Cash Flow for Q2 2026 stood at -$28.9 million, down from $32.3 million in the prior quarter.
- Over the last five years, Free Cash Flow for ENOV reached as high as $40.5 million in Q4 2023 and fell as low as -$73.1 million in Q1 2024.
- Historically, Free Cash Flow has averaged -$13.2 million across 5 years, with a median of -$8.7 million in 2023.
- Across the five-year window, Free Cash Flow tumbled 263.5% in 2024 and jumped 1128.25% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$72.7 million in 2022, then soared by 155.64% to $40.5 million in 2023, then retreated by 13.18% to $35.1 million in 2024, then decreased by 8.11% to $32.3 million in 2025, then tumbled by 189.36% to -$28.9 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$28.9 million in Q2 2026, $32.3 million in Q4 2025, and $29.1 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | -28.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -28.85 Mn |
| Apr 3, 2026 | -28.85 Mn |
| Dec 31, 2025 | 32.29 Mn |
| Dec 31, 2025 | 32.29 Mn |
| Oct 3, 2025 | 29.09 Mn |
| Oct 3, 2025 | 29.09 Mn |
| Jul 4, 2025 | 3.40 Mn |
| Jul 4, 2025 | 3.40 Mn |
| Apr 4, 2025 | -44.86 Mn |
| Apr 4, 2025 | -44.86 Mn |
| Dec 31, 2024 | 35.14 Mn |
| Dec 31, 2024 | 35.14 Mn |
| Sep 27, 2024 | 2.37 Mn |
| Sep 27, 2024 | 2.37 Mn |
| Jun 28, 2024 | -31.63 Mn |
| Jun 28, 2024 | -31.63 Mn |
| Mar 29, 2024 | -73.08 Mn |
| Mar 29, 2024 | -73.08 Mn |
| Dec 31, 2023 | 40.47 Mn |
| Dec 31, 2023 | 40.47 Mn |